ArticleJournal of exposure science & environmental epidemiology
Satellite-based PM concentrations and their application to COPD in Cleveland, OH.
Article in Journal of exposure science & environmental epidemiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Proteomics, Human Environmental Exposure, and Cardiometabolic Risk.Circulation research · 2024Observational
- Evaluating Data Product Exposure Metrics for Use in Epidemiologic Studies of Dust Storms.GeoHealth · 2023Article
- Long-term exposure to indoor air pollution and risk of tuberculosis.Indoor air · 2021Article
- Association between African Dust Transport and Acute Exacerbations of COPD in Miami.Journal of clinical medicine · 2020Article
- Contribution of Satellite-Derived Aerosol Optical Depth PMAtmosphere · 2020Article
- Considering spatial heterogeneity in the distributed lag non-linear model when analyzing spatiotemporal data.Journal of exposure science & environmental epidemiology · 2018Article
- The status of geo-environmental health in Mississippi: Application of spatiotemporal statistics to improve health and air quality.AIMS environmental science · 2018Article
- Predictive and Prognostic Biomarkers of Respiratory Diseases due to Particulate Matter Exposure.Journal of cancer prevention · 2017Review
- The Exposure Uncertainty Analysis: The Association between Birth Weight and Trimester Specific Exposure to Particulate Matter (PM2.5 vs. PM10).International journal of environmental research and public health · 2016Article
- Pollutional haze and COPD: etiology, epidemiology, pathogenesis, pathology, biological markers and therapy.Journal of thoracic disease · 2016Review
- Associations of autophagy with lung diffusion capacity and oxygen saturation in severe COPD: effects of particulate air pollution.International journal of chronic obstructive pulmonary disease · 2016Article
- Seasonal Variation in Dry Eye.Ophthalmology · 2015Article
- The view from afar: satellite-derived estimates of global PM2.5.Environmental health perspectives · 2015Article
- Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.International journal of chronic obstructive pulmonary disease · 2015Article
- Assessment of Population Exposure to Coarse and Fine Particulate Matter in the Urban Areas of Chennai, India.TheScientificWorldJournal · 2015Article
- Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection.Particle and fibre toxicology · 2014Article
- Short-term population-based non-linear concentration-response associations between fine particulate matter and respiratory diseases in Taipei (Taiwan): a spatiotemporal analysis.Journal of exposure science & environmental epidemiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A hybrid approach is proposed to estimate exposure to fine particulate matter (PM(2.5)) at a given location and time. This approach builds on satellite-based aerosol optical depth (AOD), air pollution data from sparsely distributed Environmental Protection Agency (EPA) sites and local time-space Kriging, an optimal interpolation technique. Given the daily global coverage of AOD data, we can develop daily estimate of air quality at any given location and time. This can assure unprecedented spatial coverage, needed for air quality surveillance and management and epidemiological studies. In this paper, we developed an empirical relationship between the 2 km AOD and PM(2.5) data from EPA sites. Extrapolating this relationship to the study domain resulted in 2.3 million predictions of PM(2.5) between 2000 and 2009 in Cleveland Metropolitan Statistical Area (MSA). We have developed local time-space Kriging to compute exposure at a given location and time using the predicted PM(2.5). Daily estimates of PM(2.5) were developed for Cleveland MSA between 2000 and 2009 at 2.5 km spatial resolution; 1.7 million (∼79.8%) of 2.13 million predictions required for multiyear and geographic domain were robust. In the epidemiological application of the hybrid approach, admissions for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) was examined with respect to time-space lagged PM(2.5) exposure. Our analysis suggests that the risk of AECOPD increases 2.3% with a unit increase in PM(2.5) exposure within 9 days and 0.05° (∼5 km) distance lags. In the aggregated analysis, the exposed groups (who experienced exposure to PM(2.5) >15.4 μg/m(3)) were 54% more likely to be admitted for AECOPD than the reference group. The hybrid approach offers greater spatiotemporal coverage and reliable characterization of ambient concentration than conventional in situ monitoring-based approaches. Thus, this approach can potentially reduce exposure misclassification errors in the conventional air pollution epidemiology studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.